Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

Bcl-2 expression in prostatic adenocarcinoma


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 3,651

Availability: In stock

  • Product Description

Prostate cancer is one of the most common cancers among men and is the leading cause of cancer deaths. As a result of effective PSA screening programmes in the West, most patients are diagnosed at an early favorable stage. Unfortunately, such screening programmes are not popular in India. Majority of the patients with prostatic carcinoma present in an advanced stage in our country, when treatment options are limited. Bcl-2, one of the targets for therapy, is an anti-apoptotic mediator that has been found to be involved in the molecular biology of a wide range of human cancers including prostatic cancer. Overexpression of this protein was found to be associated with progression of prostate cancer to a metastatic and hormone insensitive state characterized by poor responses to various forms of therapy. Hence, therapy against this anti-apoptotic protein could provide a treatment option for such patients. This study was undertaken to highlight the possible role of Bcl-2 in the pathogenesis of prostatic carcinoma and its progression with the hope of developing targeted therapy to combat this disease.

Product Specifications
SKU :COC29918
AuthorBhavna Nayal,Mary Mathew and Joseph Thomas
Number of Pages116
Publishing Year2012-02-07T00:00:00.000
Edition1 st
Book TypeMedicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-29 00:00:00